Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Jun 26;13(13):2175.
doi: 10.3390/diagnostics13132175.

Vaccines in Breast Cancer: Challenges and Breakthroughs

Affiliations
Review

Vaccines in Breast Cancer: Challenges and Breakthroughs

Gul Naz Fatima et al. Diagnostics (Basel). .

Abstract

Breast cancer is a problem for women's health globally. Early detection techniques come in a variety of forms ranging from local to systemic and from non-invasive to invasive. The treatment of cancer has always been challenging despite the availability of a wide range of therapeutics. This is either due to the variable behaviour and heterogeneity of the proliferating cells and/or the individual's response towards the treatment applied. However, advancements in cancer biology and scientific technology have changed the course of the cancer treatment approach. This current review briefly encompasses the diagnostics, the latest and most recent breakthrough strategies and challenges, and the limitations in fighting breast cancer, emphasising the development of breast cancer vaccines. It also includes the filed/granted patents referring to the same aspects.

Keywords: adjuvants; antigens; biomarkers; breast cancer; challenges; diagnostics; patents; therapeutics; vaccine strategies.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
The process of immunoediting carried out by cancer cells.
Figure 2
Figure 2
Immune-suppression by tumour cells.
Figure 3
Figure 3
Mechanism of a peptide-based BCV.
Figure 4
Figure 4
Diagrammatic representation of vector-based vaccines.

Similar articles

Cited by

References

    1. Dittmer J. Breast Cancer Stem Cells: Features, Key Drivers and Treatment Options. Semin. Cancer Biol. 2018;53:59–74. doi: 10.1016/j.semcancer.2018.07.007. - DOI - PubMed
    1. Fisusi F.A., Akala E.O. Drug Combinations in Breast Cancer Therapy. Pharm. Nanotechnol. 2019;7:3–23. doi: 10.2174/2211738507666190122111224. - DOI - PMC - PubMed
    1. Huang S., Yang J., Fong S., Zhao Q.J. Artificial Intelligence in Cancer Diagnosis and Prognosis: Opportunities and Challenges. Cancer Lett. 2020;471:61–71. doi: 10.1016/j.canlet.2019.12.007. - DOI - PubMed
    1. Hylton N.M., Gatsonis C.A., Rosen M.A., Lehman C.D., Newitt D.C., Partridge S.C., Bernreuter W.K., Pisano E.D., Morris E.A., Weatherall P.T., et al. Neoadjuvant Chemotherapy for Breast Cancer: Functional Tumor Volume by Mr Imaging Predicts Recurrence-Free Survival-Results from the Acrin 6657/Calgb 150007 I-Spy 1 Trial. Radiology. 2016;279:44–55. doi: 10.1148/radiol.2015150013. - DOI - PMC - PubMed
    1. Da Costa B.R.B., De Martinis B.S. Analysis of Urinary Vocs Using Mass Spectrometric Methods to Diagnose Cancer: A Review. Clin. Mass Spectrom. 2020;18:27–37. doi: 10.1016/j.clinms.2020.10.004. - DOI - PMC - PubMed

LinkOut - more resources